Lung Cancer · 2015 · 46 citations · 12 references
MedicineGeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer ProgressionLung CancerMalignant NeoplasmsNeuroendocrine TumorsOncogenic Signaling PathwaysTherapeutic ResistanceAlk Fusion GenesLung AdenocarcinomaLung Cancer PathologyPulmonary Neuroendocrine TumorsResistance Mechanism ClassificationResistance Mechanism ElucidationResistance Mechanism Identification
12
World Health Organization Classification of Tumours
CDM Fletcher, Anke van den Berg, Ineke Molenaar · 2002 · 7.1K citations
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Manabu Soda, Young Lim Choi, Munehiro Enomoto et al. · Nature · 2007 · 5.4K citations
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge et al. · New England Journal of Medicine · 2010 · 4.5K citations
Medicine, Oncology, Pharmacology +14
RET, ROS1 and ALK fusions in lung cancer
Kengo Takeuchi, Manabu Soda, Yuki Togashi et al. · Nature Medicine · 2012 · 1.3K citations
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
Ryohei Katayama, Alice T. Shaw, Tahsin Khan et al. · Science Translational Medicine · 2012 · 1.3K citations
Medicine, Oncology, Pharmacology +17